Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,739 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $200.51 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $193.89 | 10 | $0 (2024) |
| PFIZER INC. | $190.30 | 12 | $0 (2024) |
| Lilly USA, LLC | $155.12 | 8 | $0 (2021) |
| ABBVIE INC. | $115.82 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $111.08 | 6 | $0 (2021) |
| Amgen Inc. | $105.06 | 7 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $99.43 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $86.72 | 3 | $0 (2019) |
| SANOFI PASTEUR INC. | $64.52 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $162.42 | 8 | GlaxoSmithKline, LLC. ($48.68) |
| 2023 | $323.29 | 17 | Novartis Pharmaceuticals Corporation ($65.89) |
| 2022 | $319.04 | 14 | Kowa Pharmaceuticals America, Inc. ($86.98) |
| 2021 | $267.24 | 15 | Lilly USA, LLC ($64.84) |
| 2020 | $154.31 | 8 | AstraZeneca Pharmaceuticals LP ($63.51) |
| 2019 | $207.82 | 12 | Janssen Pharmaceuticals, Inc ($47.65) |
| 2018 | $230.38 | 14 | Janssen Pharmaceuticals, Inc ($39.07) |
| 2017 | $74.09 | 4 | Horizon Pharma plc ($21.16) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Inflammation | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 11/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Inflammation | ||||||
| 08/23/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological), BEYFORTUS, MENQUADFI | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Vaccines | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Hematology | ||||||
| 07/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Vaccines | ||||||
| 06/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Vaccines | ||||||
| 02/16/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Vaccines | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,338 | 5,484 | $836,698 | $149,323 |
| 2022 | 33 | 2,347 | 4,198 | $634,113 | $96,423 |
| 2021 | 39 | 2,880 | 5,160 | $707,325 | $185,928 |
| 2020 | 45 | 3,428 | 6,338 | $659,385 | $208,352 |
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $6,600 | $435.82 | 6.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 65 | 70 | $1,400 | $398.94 | 28.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 18 | $1,080 | $391.77 | 36.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 81 | 121 | $4,235 | $381.60 | 9.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 65 | 70 | $1,750 | $356.18 | 20.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 32 | 39 | $1,482 | $344.76 | 23.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 15 | 18 | $1,350 | $316.69 | 23.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 34 | 38 | $1,140 | $315.02 | 27.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 19 | $570.00 | $253.84 | 44.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 13 | $975.00 | $187.98 | 19.3% |
| 84550 | Uric acid level, blood | Office | 2023 | 18 | 30 | $600.00 | $136.98 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $910.00 | $101.25 | 11.1% |
| 84155 | Total protein level, blood | Office | 2023 | 14 | 22 | $330.00 | $80.03 | 24.3% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 11 | 18 | $270.00 | $71.98 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 711 | $284,400 | $28,776 | 10.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 65 | 65 | $45,500 | $8,693 | 19.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 210 | $21,000 | $7,762 | 37.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 227 | 434 | $32,550 | $4,534 | 13.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 66 | $9,900 | $4,507 | 45.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 82 | $22,960 | $4,310 | 18.8% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2022 | 112 | 229 | $18,320 | $4,042 | 22.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,060 | $3,896 | 95.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 181 | 232 | $16,240 | $3,841 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 168 | 168 | $67,200 | $3,535 | 5.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 195 | 259 | $19,425 | $3,413 | 17.6% |
About Dr. Satish Bankuru, M.D
Dr. Satish Bankuru, M.D is a Internal Medicine healthcare provider based in Coos Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689968943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Satish Bankuru, M.D has received a total of $1,739 in payments from pharmaceutical and medical device companies, with $162.42 received in 2024. These payments were reported across 92 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,739).
As a Medicare-enrolled provider, Bankuru has provided services to 11,993 Medicare beneficiaries, totaling 21,180 services with total Medicare billing of $640,027. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Coos Bay, OR
- Active Since 06/04/2011
- Last Updated 08/11/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689968943
Products in Payments
- ENTRESTO (Drug) $158.41
- TRELEGY ELLIPTA (Drug) $134.11
- TRULICITY (Drug) $123.93
- ELIQUIS (Drug) $102.23
- Livalo (Drug) $99.43
- VRAYLAR (Drug) $84.39
- Otezla (Drug) $63.04
- SYMBICORT (Drug) $56.82
- XARELTO (Drug) $53.72
- VAXELIS (Biological) $38.63
- MYRBETRIQ (Drug) $36.92
- LEQVIO (Drug) $35.48
- TUDORZA PRESSAIR (Drug) $33.02
- INVOKANA (Drug) $33.00
- UBRELVY (Drug) $31.57
- Repatha (Biological) $29.31
- DUPIXENT (Biological) $28.18
- CHANTIX (Drug) $27.59
- FLUZONE HIGH-DOSE (Biological) $25.89
- Vascepa (Drug) $23.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Coos Bay
Stacy Newman, Md, MD
Internal Medicine — Payments: $3,909
Carol Frank, Md, MD
Internal Medicine — Payments: $2,757
Dr. Joseph El Youssef, M.d, M.D
Internal Medicine — Payments: $1,892
Dr. Basil Pittenger, Md, MD
Internal Medicine — Payments: $744.47
Wendy Haack, D.o, D.O
Internal Medicine — Payments: $699.50
Bhavani Peddagovindu, Md, MD
Internal Medicine — Payments: $674.59